OrbiMed Capital GP VII LLC

Director at MBX Biosciences, Inc. · on record since Sep 17, 2024
10% owner at MBX Biosciences, Inc. · on record since Sep 17, 2024
Director at Lomond Therapeutics Holdings, Inc. · on record since Nov 5, 2024
10% owner at Theseus Pharmaceuticals, Inc. · on record since Oct 14, 2021
Director at Q32 Bio Inc. · on record since Jun 1, 2026
10% owner at Q32 Bio Inc. · on record since Jun 1, 2026
Director at Electra Therapeutics, Inc. · on record since Sep 18, 2026
10% owner at Electra Therapeutics, Inc. · on record since Sep 23, 2026
10% owner at Synthorx, Inc. · on record since Dec 13, 2018
Director at Sierra Oncology, Inc. · on record since Nov 26, 2019
10% owner at Sierra Oncology, Inc. · on record since Nov 26, 2019
Director at Arcutis Biotherapeutics, Inc. · on record since Jan 30, 2020
10% owner at Arcutis Biotherapeutics, Inc. · on record since Jan 30, 2020
10% owner at Passage BIO, Inc. · on record since Feb 27, 2020
Director at Enliven Therapeutics, Inc. · on record since Mar 16, 2020
10% owner at Enliven Therapeutics, Inc. · on record since Mar 16, 2020
Director at Fusion Pharmaceuticals Inc. · on record since Jun 25, 2020
Director at Repare Therapeutics Inc. · on record since Jun 25, 2020
10% owner at · on record since Jun 18, 2020
Director at · on record since Apr 13, 2020
10% owner at · on record since Jul 16, 2020
Director at · on record since Oct 28, 2020
10% owner at · on record since Oct 28, 2020
Director at · on record since Dec 9, 2020
10% owner at · on record since Dec 9, 2020
Director at · on record since Feb 9, 2021
10% owner at · on record since Feb 9, 2021
Director at · on record since Dec 17, 2021
Director at · on record since Jan 21, 2022
Director at · on record since Sep 21, 2022
10% owner at · on record since Sep 21, 2022
Director at · on record since Sep 24, 2026
10% owner at · on record since Sep 24, 2026

Insider trading activity of OrbiMed Capital GP VII LLC

Transactions on record: 98; since Dec 13, 2018

Open-market buys: 36; $97.6M

Open-market sells: 26; $31.7M

Companies traded: 12; last filing Apr 17, 2025

Figures computed from official regulatory filings — .

Companies where OrbiMed Capital GP VII LLC has traded

27 tx · $10M · Apr 17, 2025
13 tx · $10M · Nov 5, 2024
9 tx · $57.9M · May 20, 2024
6 tx · $742.7K · Aug 2, 2023
9 tx · $3.7M · May 2, 2023
5 tx · $5.1M · Sep 21, 2022
6 tx · $8.9M · Aug 18, 2022
4 tx · $19.7M · Jun 28, 2022
7 tx · $2M · Jan 21, 2022
4 tx · $274.8K · Sep 8, 2021
5 tx · $6M · Apr 13, 2020
3 tx · $15M · Dec 13, 2018

Track record of OrbiMed Capital GP VII LLC

Statistical track record

Free account

Open-market buys: 39

Last buy: May 2, 2023

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of OrbiMed Capital GP VII LLC

Co-insiders of OrbiMed Capital GP VII LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Passage BIO, Inc.Listing on record	Apr 17, 2025	Sell	-10,326	0.38 USD	$3.9K	SEC
Passage BIO, Inc.Listing on record	Apr 17, 2025	Sell	-77,090	0.33 USD	$25.4K	SEC
Passage BIO, Inc.Listing on record	Apr 17, 2025	Sell	-61,638	0.33 USD	$20.3K	SEC
Passage BIO, Inc.Listing on record	Jan 8, 2025	Sell	-75,007	0.68 USD	$51K	SEC
Passage BIO, Inc.Listing on record	Jan 8, 2025	Sell	-52,536	0.71 USD	$37.3K	SEC
Passage BIO, Inc.Listing on record	Jan 8, 2025	Sell	-19,481	0.77 USD	$15K	SEC
Passage BIO, Inc.Listing on record	Dec 26, 2024	Sell	-230,321	0.60 USD	$138.2K	SEC
Passage BIO, Inc.Listing on record	Dec 6, 2024	Sell	-20,903	0.82 USD	$17.1K	SEC
Passage BIO, Inc.Listing on record	Dec 6, 2024	Sell	-76,200	0.79 USD	$60.2K	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	Award	155,120	4.00 USD	$620.5K	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	OtherD (derivative)	-389,078	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	Award	808,894	4.00 USD	$3.2M	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	Other	389,078	3.60 USD	$1.4M	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	OtherD (derivative)	-215,146	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	Other	215,146	3.20 USD	$688.5K	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	Other	323,916	3.20 USD	$1M	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	Other	230,753	3.60 USD	$830.7K	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	OtherD (derivative)	-74,613	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	Award	479,736	4.00 USD	$1.9M	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	Other	74,613	3.60 USD	$268.6K	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	OtherD (derivative)	-230,753	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	OtherD (derivative)	-323,916	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Passage BIO, Inc.Listing on record	Sep 18, 2024	Sell	-25,631	0.73 USD	$18.7K	SEC
Passage BIO, Inc.Listing on record	Sep 18, 2024	Sell	-111,400	0.73 USD	$81.3K	SEC
Passage BIO, Inc.Listing on record	Sep 18, 2024	Sell	-63,100	0.74 USD	$46.7K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Passage BIO, Inc.Listing on record	Apr 17, 2025	Sell	-10,326	0.38 USD	$3.9K	SEC
Passage BIO, Inc.Listing on record	Apr 17, 2025	Sell	-77,090	0.33 USD	$25.4K	SEC
Passage BIO, Inc.Listing on record	Apr 17, 2025	Sell	-61,638	0.33 USD	$20.3K	SEC
Passage BIO, Inc.Listing on record	Jan 8, 2025	Sell	-75,007	0.68 USD	$51K	SEC
Passage BIO, Inc.Listing on record	Jan 8, 2025	Sell	-52,536	0.71 USD	$37.3K	SEC
Passage BIO, Inc.Listing on record	Jan 8, 2025	Sell	-19,481	0.77 USD	$15K	SEC
Passage BIO, Inc.Listing on record	Dec 26, 2024	Sell	-230,321	0.60 USD	$138.2K	SEC
Passage BIO, Inc.Listing on record	Dec 6, 2024	Sell	-20,903	0.82 USD	$17.1K	SEC
Passage BIO, Inc.Listing on record	Dec 6, 2024	Sell	-76,200	0.79 USD	$60.2K	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	Award	155,120	4.00 USD	$620.5K	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	OtherD (derivative)	-389,078	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	Award	808,894	4.00 USD	$3.2M	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	Other	389,078	3.60 USD	$1.4M	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	OtherD (derivative)	-215,146	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	Other	215,146	3.20 USD	$688.5K	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	Other	323,916	3.20 USD	$1M	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	Other	230,753	3.60 USD	$830.7K	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	OtherD (derivative)	-74,613	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	Award	479,736	4.00 USD	$1.9M	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	Other	74,613	3.60 USD	$268.6K	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	OtherD (derivative)	-230,753	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Lomond Therapeutics Holdings, Inc.Listing unverified	Nov 5, 2024	OtherD (derivative)	-323,916	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Passage BIO, Inc.Listing on record	Sep 18, 2024	Sell	-25,631	0.73 USD	$18.7K	SEC
Passage BIO, Inc.Listing on record	Sep 18, 2024	Sell	-111,400	0.73 USD	$81.3K	SEC
Passage BIO, Inc.Listing on record	Sep 18, 2024	Sell	-63,100	0.74 USD	$46.7K	SEC